Today before the opening bell, VistaGen
Therapeutics announced its reception of a Notice of Allowance from the Canadian
Intellectual Property Office. The Notice of Allowance enables further expansion
of VistaGen Therapeutics’ intellectual property portfolio, which consists of
pluripotent stem cell culture systems that produce human cells of the endoderm
lineage, including liver, lung, pancreas, parathyroid and thyroid cells.
The notice pertains to Canadian Patent
Application No. 2,487,058, which is exclusively licensed to VistaGen
Therapeutics by the Icahn School of Medicine at Mt. Sinai in New York and
entitled “Mesoderm and Definitive Endoderm Cell Populations”. This new
development builds on VistaGen Therapeutics’ recent reception of another Notice
of Allowance for Canadian Patent Application 2,684,022, both of which
strengthen the company’s intellectual property portfolio relating to a number
of pluripotent stem cell projects VistaGen Therapeutics has been considering
pursuing in Canada.
These include: projects that involve liver
safety and liver toxicity-based drug rescue; customized drug discovery assays
for therapies to treat liver disease and diabetes; and exploratory nonclinical
studies for potential regenerative medicine applications involving beta islet
cells and other cells of the endoderm lineage.
A biotechnology company, VistaGen
Therapeutics is focused on using pluripotent stem cell technology for
applications in drug rescue, drug discovery, and regenerative medicine.
For more information, visit: www.vistagen.com
About
QualityStocks
QualityStocks is committed to connecting
subscribers with companies that have huge potential to succeed in the short and
long-term future. We offer several ways for investors to find, evaluate, and
learn more about investing in these companies.
Sign up for “The QualityStocks Daily
Newsletter” at www.QualityStocks.net
The Quality Stocks Daily Blog http://blog.qualitystocks.net
The Quality Stocks Daily Videos http://videocharts.qualitystocks.net
The Quality Stocks “Ones to Watch” http://gotstocks.qualitystocks.net
Please see disclaimer on the QualityStocks
website: http://disclaimer.qualitystocks.net
No comments:
Post a Comment